GeneDx Holdings (WGS) Q1 2024 Earnings
WGS·Reported April 29, 2024·After market close
GeneDx Holdings reported Q1 2024 revenue of $62.4M, beat analyst consensus of $58.4M by $4.1M. Diluted EPS came in at $-0.33, beat the $-0.68 consensus by $0.35.
Revenue
$62.4Mbeat by $4.1M
Consensus: $58.4MDiluted EPS
$-0.33beat by $0.35
Consensus: $-0.68
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about GeneDx Holdings's Q1 2024 earnings report.
GeneDx Holdings (WGS) reported Q1 2024 earnings on April 29, 2024 after market close.
GeneDx Holdings reported revenue of $62.4M and diluted EPS of $-0.33 for Q1 2024.
Revenue beat the consensus estimate of $58.4M by $4.1M. EPS beat the consensus estimate of $-0.68 by $0.35.
You can read the 10-Q periodic report (0001818331-24-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.